237 related articles for article (PubMed ID: 33994344)
41. Trans-rectal ultrasound-guided hybrid intra-cavitary and interstitial brachytherapy in carcinoma cervix: A feasibility study from a tertiary cancer center in India.
Bajwa HK; Singareddy R; Talluri AK; Kauser H; Boja DR; Srikanth G; Raju AK; Sresty NM; Mytri V
J Contemp Brachytherapy; 2023 Jun; 15(3):198-205. PubMed ID: 37425200
[TBL] [Abstract][Full Text] [Related]
42. Commissioning and Dosimetric Results of an Indigenously Developed Intra-Vaginal Template for Interstitial Plus Intracavitary High dose Rate Image-Guided Brachytherapy of Advanced Cervix Cancer.
Kaliyaperumal V; Banerjee S; Kataria T; Abraham SK; Kamaraj D; Tamilselvan S; Gupta D; Bisht SS; Narang K; Shishak S
J Med Phys; 2022; 47(4):322-330. PubMed ID: 36908497
[TBL] [Abstract][Full Text] [Related]
43. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Moerland MA; Witteveen PO; Schreuder HW; van Dorst EB; Jürgenliemk-Schulz IM
Radiother Oncol; 2013 Apr; 107(1):69-74. PubMed ID: 23639580
[TBL] [Abstract][Full Text] [Related]
44. Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
Han DY; Safigholi H; Soliman A; Ravi A; Leung E; Scanderbeg DJ; Liu Z; Owrangi A; Song WY
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):440-448. PubMed ID: 27598809
[TBL] [Abstract][Full Text] [Related]
45. Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report.
Takagawa Y; Izumi S; Takahashi E; Kita M
BMC Womens Health; 2024 Apr; 24(1):249. PubMed ID: 38637783
[TBL] [Abstract][Full Text] [Related]
46. Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy.
Scott AA; Weersink M; Liu ZA; Milosevic M; Croke J; Fyles A; Lukovic J; Rink A; Beiki-Ardakani A; Borg J; Xie J; Chan K; Ballantyne H; Skliarenko J; Conway JL; Gladwish A; Weersink RA; Han K
Brachytherapy; 2023; 22(2):146-156. PubMed ID: 36528475
[TBL] [Abstract][Full Text] [Related]
47. Impact of different dose prescription schedules on EQD
Kumar M; Thangaraj R; Alva RC; Koushik K; Ponni A; Achar JM
J Contemp Brachytherapy; 2019 Apr; 11(2):189-193. PubMed ID: 31139229
[TBL] [Abstract][Full Text] [Related]
48. Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
Mahantshetty U; Krishnatry R; Hande V; Jamema S; Ghadi Y; Engineer R; Chopra S; Gurram L; Deshpande D; Shrviastava S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):608-617. PubMed ID: 29280456
[TBL] [Abstract][Full Text] [Related]
49. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study.
Fokdal L; Sturdza A; Mazeron R; Haie-Meder C; Tan LT; Gillham C; Šegedin B; Jürgenliemk-Schultz I; Kirisits C; Hoskin P; Pötter R; Lindegaard JC; Tanderup K
Radiother Oncol; 2016 Sep; 120(3):434-440. PubMed ID: 27113795
[TBL] [Abstract][Full Text] [Related]
50. Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial.
Murakami N; Watanabe M; Uno T; Sekii S; Tsujino K; Kasamatsu T; Machitori Y; Aoshika T; Kato S; Hirowatari H; Kaneyasu Y; Nakagawa T; Ikushima H; Ando K; Murata M; Yoshida K; Yoshioka H; Murata K; Ohno T; Okonogi N; Saito A; Ichikawa M; Okuda T; Tsuchida K; Sakurai H; Yoshimura R; Yoshioka Y; Yorozu A; Okamoto H; Inaba K; Kato T; Igaki H; Itami J
Jpn J Clin Oncol; 2022 Aug; 52(8):859-868. PubMed ID: 35470390
[TBL] [Abstract][Full Text] [Related]
51. Dosimetric comparison of two different applicators and rectal retraction methods used in inverse optimization-based intracavitary brachytherapy for cervical cancer.
Biltekin F; Gultekin M; Yilmaz MT; Yildiz F
J Contemp Brachytherapy; 2020 Feb; 12(1):35-43. PubMed ID: 32190068
[TBL] [Abstract][Full Text] [Related]
52. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
[TBL] [Abstract][Full Text] [Related]
53. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
54. Clinical outcomes using a 3D printed tandem-needle-template and the EMBRACE-II planning aims for image guided adaptive brachytherapy in locally advanced cervical cancer.
Cobussen A; Petric P; Wulff CN; Buus S; Spejlborg H; Nielsen SK; Traberg A; Meisner B; Hokland S; Lindegaard JC
Acta Oncol; 2023 Nov; 62(11):1470-1478. PubMed ID: 37594195
[TBL] [Abstract][Full Text] [Related]
55. Outpatient template-guided permanent interstitial brachytherapy using
Feddock J; Aryal P; Steber C; Edwards J; Cheek D; Randall M
Brachytherapy; 2017; 16(2):393-401. PubMed ID: 28139423
[TBL] [Abstract][Full Text] [Related]
56. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
57. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
[TBL] [Abstract][Full Text] [Related]
58. Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry.
Marar M; Simiele E; Niedermayr T; Kidd EA
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):111-119. PubMed ID: 35654306
[TBL] [Abstract][Full Text] [Related]
59. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.
Nishikawa R; Yoshida K; Ebina Y; Omoteda M; Miyawaki D; Ishihara T; Ejima Y; Akasaka H; Satoh H; Kyotani K; Takahashi S; Sasaki R
J Radiat Res; 2018 May; 59(3):316-326. PubMed ID: 29518234
[TBL] [Abstract][Full Text] [Related]
60. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
